This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In Konya

AnxietyBehavioralFrom 18 Years to 35 Years

Countries: Türkiye
Sponsor: Hediye Karakoç
Condition: Anxiety

View study

CompletedNCT00169611

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

This summary needs review. Please check the official study record and contact the research team for details.

In Lyon

ADHDDrugFrom 7 Years to 12 Years

Countries: France
Sponsor: Hospices Civils de Lyon
Condition: ADHD

View study

CompletedNCT00376233

Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Jena

SchizophreniaOtherFrom 18 Years to 40 Years

Countries: Germany
Sponsor: University of Jena
Condition: Schizophrenia

View study

CompletedNCT02458924

Niacin Skin Flush Response in people with Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

Location not clearly listed

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries
Sponsor: Isfahan University of Medical Sciences
Condition: Schizophrenia

View study

CompletedNCT01720095

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Halifax

SchizophreniaDrugFrom 18 Years to 35 Years

Countries: Canada
Sponsor: Nova Scotia Health Authority
Condition: Schizophrenia

View study

CompletedNCT00573248

Nicotine and Behavior in Adult ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Irvine

ADHDDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Irvine
Condition: ADHD

View study

CompletedNCT00135772

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

This summary needs review. Please check the official study record and contact the research team for details.

In Piscataway

Schizophrenia, AddictionOtherFrom 18 Years to 70 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Schizophrenia, Addiction

View study

CompletedNCT01213524

Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Providence

Schizophrenia, AddictionBehavioralFrom 18 Years to 99 Years

Countries: United States
Sponsor: Brown University
Condition: Schizophrenia, Addiction

View study

CompletedNCT03580525

Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven

AddictionDrugFrom 18 Years to 35 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

View study

CompletedNCT05159934

Nicotine Differences in Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.